Overexpression of PARP1 and other DNA damage repair proteins may aid in repairing DNA lesions caused by Top2 inhibitors, allowing tumor cells to withstand treatment involving Top2 inhibitors [107,108]. This evidence concerns the gene PARP1 and neoplasm.